SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon acquires stake in Ampin C&I Power Twelve

11 Jun 2026 Evaluate

Biocon has acquired an equity stake in Ampin C&I Power Twelve (AMPIN), a Special Purpose Vehicle (SPV) formed for the generation and supply of solar power, by investing around Rs 5.47 crore towards the subscription of 54.76 lakh equity shares. 

To enhance the renewable based power consumption, Biocon has acquired and will maintain equity stake in AMPIN throughout the terms of the Power Purchase Agreement and Share Purchase, Subscription and Shareholders Agreement (Agreements) entered between the Company and AMPIN to maintain captive status as per Electricity Act. This acquisition aligns with the company’s renewable energy objectives, supporting the procurement of green energy and advancing its decarbonization goals and will help the company in reducing its energy cost and carbon footprint.

With the above investment, the company will hold 59.76 lakh Equity shares of AMPIN representing 37.77% of its paid-up share capital (on an undiluted basis) as on date. However, post the proposed investment by other entities in AMPIN, the aforesaid percentage of investment of the Company will stand reduced to 15.91% of the paid-up share capital of AMPIN (on a fully diluted basis) as per the terms of the Agreements entered by the Company.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

418.10 1.30 (0.31%)
12-Jun-2026 13:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.95
Dr. Reddys Lab 1273.00
Cipla 1393.40
Zydus Lifesciences 1102.45
Lupin 2281.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: